Evidence map›Paper›PMID 24078696›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice.

Caroline G McPhee, Jason A Bubier, Thomas J Sproule, Giljun Park, Martin P Steinbuck, William H Schott, Gregory J Christianson, Herbert C Morse, Derry C Roopenian

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Emerging immunotherapies for autoimmune kidney disease.Human vaccines & immunotherapeutics · 2019
    Review
  12. Review
  13. Review
  14. Article
  15. An update on lupus animal models.Current opinion in rheumatology · 2017
    Review
  16. Article
  17. Article
  18. Altered B cell signalling in autoimmunity.Nature reviews. Immunology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Caroline G McPheeThe Jackson Laboratory, Bar Harbor, ME 04609.
Jason A Bubier
Thomas J Sproule
Giljun Park
Martin P Steinbuck
William H Schott
Gregory J Christianson
Herbert C Morse
Derry C Roopenian
Jackson Laboratory · USNational Institutes of Health · US

Funding

Molecular Regulation of B-Cell Differentiation and FunctionZIAAI001024 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MORSE, HERBERT · 2009 to 2018
$8.3M
Intramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001024NIAID NIH HHS Y99 AI999999
6 · The paper itself

Abstract

The pleiotropic cytokine IL-21 is implicated in the pathogenesis of human systemic lupus erythematosus by polymorphisms in the molecule and its receptor (IL-21R). The systemic lupus erythematosus-like autoimmune disease of BXSB.Yaa mice is critically dependent on IL-21 signaling, providing a model for understanding IL-21/IL-21R signaling in lupus pathogenesis. In this study, we generated BXSB.Yaa mice selectively deficient in IL-21R on B cells, on all T cells, or on CD8(+) T cells alone and examined the effects on disease. We found that IL-21 signaling to B cells is essential for the development of all classical disease manifestations, but that IL-21 signaling also supports the expansion of central memory, CD8(+) suppressor cells and broadly represses the cytokine activity of CD4(+) T cells. These results indicate that IL-21 has both disease-promoting and disease-suppressive effects in the autoimmune disease of BXSB.Yaa mice.

Indexed as

AnimalsB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytokinesInterleukin-21InterleukinsLupus Erythematosus, SystemicMaleMiceMice, TransgenicReceptors, Interleukin-21Signal TransductionCytokinesInterleukin-21InterleukinsReceptors, Interleukin-21

Identifiers

PMID24078696
PMCPMC3807747
OpenAlexW1846376083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.